On March 14, 2018, Thermo Fisher Scientific (TMO) stock started trading ex-dividend.
On March 14, 2018, Thermo Fisher Scientific (TMO) closed at $213.46 per share.
As of March 15, 2018, Thermo Fisher Scientific (TMO) was trading at a forward PE (price-to-earnings) ratio of 19.2x.
Thermo Fisher Scientific offers products including analytical instruments, reagents, equipment, and consumables, diagnostics and research software, and services.
In 2018, Dentsply Sirona (XRAY) is expected to register flat margins or a decline in EBIT (earnings before income and tax) margin.
For fiscal 2018, the company expects its sales to be in the range of $4.2 billion–$4.25 billion.
Dentsply Sirona plans to reinvest these savings and other available capital into company’s R&D initiatives to accelerate innovation and sales and marketing strategies.
Although Dentsply Sirona has given a disappointing performance recently, the company is still confident that it can gain a higher market share going forward.
Dentsply Sirona has a new management team that is working toward a more successful integration because it delivered lower-than-expected synergies in 2017.
Dentsply Sirona has an industry-leading R&D budget with more than 600 scientists and engineers. The company invests $125 million per year on R&D.